Diet
905 articles
When Certain Chemotherapy Drugs Are in Short Supply
It’s been all over the news–some chemotherapy drugs are in short supply. Dr. Allyson Ocean explains a doctor’s options in these situations.
New and Wonderful Things
Long-term survivor Camille Moses updates Let’s Win on her activities as an advocate for research funding and patients in treatment.
Compassionate Use: An Option Beyond Standard of Care
Investigational drugs can be accessed through the FDA’s compassionate use program. Learn more about how this can be used in pancreatic cancer treatments.
Every Day is a Good Day
Ed Duncan is a long-term survivor of pancreatic cancer. As survivor he has a stronger appreciation for life, and a renewed bond with his wife Kathie.
Let’s Win Announces Let’s Learn Webinar Series
Are you a health care professional who wants to know more about the risks, symptoms, and treatments for pancreatic cancer? Join our webinars!
Where We Are with COVID-19—A Wrap-Up
In a final COVID-19 Tip of the Week, pancreatic cancer patients need to continue social distancing, wearing masks, and washing hands frequently.
Every Day is a Gift
Kenny Vickers traveled a long road to recovery after what he thought was an ulcer turned out to be pancreatic cancer. Now he is a long-term survivor.
What Will You Do With Your Dash?
G. Paris Johnson is a long-term survivor of pancreatic cancer. She is now focused on advocacy and making the most of her life.
My Strength Comes From My Mother
Kim Vernick credits her mother for passing on the strength and positivity she has needed as a long-term survivor of pancreatic cancer.
Sharing My Knowledge With Others
David Dessert knew his family carried BRCA2, and told his doctor after his pancreatic cancer diagnosis. This led to a better treatment plan.
Never Ever Ever Give Up
Lynne Holcomb turned to a clinical trial when standard treatment was not stopping her stage IV pancreatic cancer.
Plenty to Live For
Steven was diagnosed with stage IV pancreatic cancer in 2012. Now a long-term survivor, he asked himself “What do I have to live for?” There was plenty.
CAR T Cell Trial Targets Mesothelin
In an immunotherapy clinical trial, Dr. Mark O’Hara is using CAR T cells to attack mesothelin-expressing tumor cells in pancreatic cancer.
Tough Tortoise of a Drug Beating Metastatic Pancreatic Cancer
Rexahn Pharmaceuticals is testing RX-3117, a slow-releasing drug similar to gemcitabine, in a clinical trial for metastatic pancreatic cancer patients.
Testing a New Drug to Attack Pancreatic Tumor Blood Vessels
A clinical trial is testing a new drug combination that damages the tumor blood vessels and allows chemotherapy drugs to enter the tumor.